HONG KONG--(BUSINESS WIRE)-- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated ...
SINOVAC’s COVID-19 vaccine, CoronaVac®, has been granted emergency use approval or conditional marketing authorization by over 50 countries or regions worldwide. Healive®, the hepatitis A vaccine ...
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it had signed an advance ...
Researchers at the Department of Microbiology of the University of Hong Kong (HKU) have found that most individuals after given two doses of the vaccine (either BioNtech or Coronavac) do not produce ...
Sinovac's COVID-19 vaccine was an estimated 98% effective at preventing death in Indonesian health workers. It was also 96% effective at preventing hospitalization, Indonesian officials said. The data ...
(RTTNews) - Chinese biopharmaceutical company Sinovac Biotech Ltd. (SVA) announced that CoronaVac, an innovative, inactivated coronavirus vaccine developed by its subsidiary Sinovac Life Sciences Co., ...
Aug 16 (Reuters) - The risk of Bell's Palsy, a type of facial paralysis, is higher after Sinovac Biotech Ltd's (SVA.O), opens new tab COVID-19 vaccine CoronaVac, but should not be a deterrent to ...
BRASILIA, Jan 20 (Reuters) - Brazilian health regulator Anvisa on Thursday approved the emergency use of Sinovac Biotech's (SVA.O), opens new tab COVID-19 vaccine Coronavac on those without underlying ...
In a new study under consideration at a Nature Portfolio Journal and published on the preprint server Research Square*, researchers investigated the efficacy of CoronaVac, a coronavirus disease 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results